CIR circadian technologies limited

Another Circadian investment hits a milestone.Headline...

  1. 7,932 Posts.
    lightbulb Created with Sketch. 253
    Another Circadian investment hits a milestone.

    Headline News
    Optiscan: Pentax ISC 1000 now in full-scale production
    By RWE Australian Business News, 06 Mar 2006


    Sydney - Monday - March 6: (RWE Australian Business News) -
    Optiscan Imaging Ltd (ASX code: OIL) reports Pentax Corporation today
    announced the sales release of the Pentax ISC 1000 flexible
    endo-microscope.

    Pentax's full-scale production release signals the start of
    significant increases in Optiscan's revenues, margins and royalties.

    "Full-scale production release by Pentax is a watershed event
    for Optiscan and the commercialisation of its unique endo-microscope
    technology," Optiscan CEO Mr Matthew Barnett said.

    "The Pentax ISC 1000 endo-microscope will underpin Optiscan's
    transition to a high-growth and profitable medical technology business."

    The ISC 1000 flexible endo-microscope is a major product
    initiative for Pentax.

    It provides doctors with previously unobtainable levels of
    magnification (1000x) and resolution (0.001mm), enabling them to observe
    cells and cellular structures in real time during an endoscopic
    examination.

    Introducing endo-microscopy into the $US1.2 billion global
    flexible endoscope market is a key component of Pentax's aggressive
    growth plan for its Life Care Division.

    Strong customer demand for endo-microscopy has already been
    created through a combination of excellent clinical trial results,
    publications in leading peer-reviewed industry journals, high-profile
    presentations at international congresses and promotional activity.

    Optiscan shares rose 2.5c to 38c this morning.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.